Iclaprim
Iclaprim
Iclaprim (pronounced: i-klap-rim) is a synthetic antibiotic specifically designed to combat serious skin infections and pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA).
Etymology
The term "Iclaprim" is a coined name with no specific etymology. It is a proprietary name for a synthetic antibiotic.
Usage
Iclaprim is used in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and hospital-acquired bacterial pneumonia (HABP), especially those caused by MRSA. It is a dihydrofolate reductase inhibitor, which means it works by blocking the action of an enzyme that bacteria need to multiply.
Related Terms
- Antibiotic: A type of antimicrobial substance active against bacteria.
- Methicillin-resistant Staphylococcus aureus (MRSA): A bacterium that causes infections in different parts of the body and is resistant to some commonly used antibiotics.
- Dihydrofolate reductase inhibitor: A type of drug that blocks the action of an enzyme that bacteria need to multiply.
- Pneumonia: An inflammatory condition of the lung affecting primarily the small air sacs known as alveoli.
- Acute bacterial skin and skin structure infections (ABSSSI): Infections that involve deeper skin tissue or occur after surgery.
- Hospital-acquired bacterial pneumonia (HABP): Pneumonia that occurs 48 hours or more after admission, which was not incubating at the time of admission.
External links
- Medical encyclopedia article on Iclaprim
- Wikipedia's article - Iclaprim
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski